Skip to main content
Erschienen in: Digestive Diseases and Sciences 3/2014

01.03.2014 | Original Article

Small Intestinal Bacterial Overgrowth in Gastroparesis

verfasst von: Nina S. George, Abhinav Sankineni, Henry P. Parkman

Erschienen in: Digestive Diseases and Sciences | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Objective

To determine symptoms of small intestinal bacterial overgrowth (SIBO) in gastroparesis patients.

Methods

Patients undergoing LBT (lactulose breath test) for evaluation of SIBO were included. LBT was considered positive on the basis of three conventional criteria: (1) hydrogen level increase >20 ppm above baseline by 90 min (H2@90min); (2) dual hydrogen peaks (>10 ppm increase over baseline before second peak >20 ppm (DPHBT); and (3) breath methane increase of >20 ppm above baseline by 90 min. Results of gastric emptying scintigraphy (GES) were recorded. Patients completed the Patient Assessment of Upper Gastrointestinal Disorders-Symptom Severity Index.

Results

Of 740 patients who underwent LBT from December 2009 to August 2011, 471 underwent GES, with 201 having delayed GES. Of patients with delayed GES who underwent LBT 87 % were female, 23 % diabetic, 49 % used gastric acid suppressants, 29 % used opiate analgesics, 35 % used pro-motility medications, and 27 % had a history of gastrointestinal surgery. Overall, 79 (39 %) patients with gastroparesis had evidence of SIBO by LBT: 30 (15 %) had positive H2@90min, 53 (26 %) positive DPHBT, and 6 (3 %) positive breath methane test. In gastroparesis patients with positive H2@90min, there was increased severity of bloating (3.80 ± 0.20 vs 3.29 ± 0.12; P = 0.02), early satiety (3.57 ± 0.27 vs 3.05 ± 0.13; P = 0.045), and postprandial fullness (4.20 ± 0.18 vs 3.52 ± 0.12; P < 0.01) compared with negative H2@90min patients. No significant difference in symptom severity was seen between positive and negative DPHBT gastroparesis patients.

Conclusion

In our cohort, 39 % of gastroparesis patients tested positive for SIBO by LBT. Positive H2@90min testing by LBT was associated with increased symptoms of bloating and excessive fullness during and after meals.
Literatur
1.
Zurück zum Zitat Belkind-Gerson J, Kuo B. Gastroparesis: a comprehensive review. Ann Gastroenterol Hepatol. 2011;2:1–11. Belkind-Gerson J, Kuo B. Gastroparesis: a comprehensive review. Ann Gastroenterol Hepatol. 2011;2:1–11.
2.
Zurück zum Zitat Khayyam U, Sachdeva P, Gomez J, et al. Assessment of symptoms during gastric emptying scintigraphy to correlate symptoms to delayed gastric emptying. Neurogastroenterol Motil. 2010;22:539–545.PubMed Khayyam U, Sachdeva P, Gomez J, et al. Assessment of symptoms during gastric emptying scintigraphy to correlate symptoms to delayed gastric emptying. Neurogastroenterol Motil. 2010;22:539–545.PubMed
3.
Zurück zum Zitat Reddymasu SC, McCallum RW. Small intestinal bacterial overgrowth in gastroparesis: are there any predictors? J Clin Gastroenterol. 2010;44:e8–e13.PubMedCrossRef Reddymasu SC, McCallum RW. Small intestinal bacterial overgrowth in gastroparesis: are there any predictors? J Clin Gastroenterol. 2010;44:e8–e13.PubMedCrossRef
4.
Zurück zum Zitat Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010;16:2978–2990.PubMedCrossRef Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol. 2010;16:2978–2990.PubMedCrossRef
5.
Zurück zum Zitat Pimental M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000;95:3503–3506.CrossRef Pimental M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol. 2000;95:3503–3506.CrossRef
6.
Zurück zum Zitat Bouhnik Y, Alain S, Attar A, et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol. 1999;94:1327–1331.PubMedCrossRef Bouhnik Y, Alain S, Attar A, et al. Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol. 1999;94:1327–1331.PubMedCrossRef
7.
8.
Zurück zum Zitat Yu D, Cheeseman F, Vanner S. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut. 2011;60:334–340.PubMedCrossRef Yu D, Cheeseman F, Vanner S. Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS. Gut. 2011;60:334–340.PubMedCrossRef
9.
Zurück zum Zitat Rhodes JM, Middelton P, Jewell P. The lactulose hydrogen breath test as a diagnostic test for small-bacterial overgrowth. Scand J Gastroenterol. 1979;14:333–367.PubMedCrossRef Rhodes JM, Middelton P, Jewell P. The lactulose hydrogen breath test as a diagnostic test for small-bacterial overgrowth. Scand J Gastroenterol. 1979;14:333–367.PubMedCrossRef
10.
Zurück zum Zitat King CE, Toskes PP. Comparison of the 1-gram [14C] xylose, 10-gram lactulose-H2, and 80 gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology. 1986;91:1447–1451.PubMed King CE, Toskes PP. Comparison of the 1-gram [14C] xylose, 10-gram lactulose-H2, and 80 gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology. 1986;91:1447–1451.PubMed
11.
Zurück zum Zitat Hejazi RA, McCallum RW. Chapter 16: breath tests for small intestinal bacterial overgrowth. In: Parkman HP, McCallum RW, Rao SSC, eds. GI motility testing: a laboratory and office handbook. Thorofare, NJ: SLACK Incorporated; 2011:145–150. Hejazi RA, McCallum RW. Chapter 16: breath tests for small intestinal bacterial overgrowth. In: Parkman HP, McCallum RW, Rao SSC, eds. GI motility testing: a laboratory and office handbook. Thorofare, NJ: SLACK Incorporated; 2011:145–150.
12.
Zurück zum Zitat Revick DA, Rentz AM, Dubois D, et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of patient reported assessment of severity of gastroparesis symptoms. Qual Life Res. 2004;13:833–844.CrossRef Revick DA, Rentz AM, Dubois D, et al. Gastroparesis Cardinal Symptom Index (GCSI): development and validation of patient reported assessment of severity of gastroparesis symptoms. Qual Life Res. 2004;13:833–844.CrossRef
13.
Zurück zum Zitat Ghoshal UC, Ghoshal U, Das K, Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian Soc Gastroenterol. 2006;25:1–10. Ghoshal UC, Ghoshal U, Das K, Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time. Indian Soc Gastroenterol. 2006;25:1–10.
14.
Zurück zum Zitat Malagelada JR, Rees WDW, Mazzotta LJ, Go VLW. Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanecol. Gastroenterology. 1980;78:286–293.PubMed Malagelada JR, Rees WDW, Mazzotta LJ, Go VLW. Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanecol. Gastroenterology. 1980;78:286–293.PubMed
15.
Zurück zum Zitat Camilleri M, Malagelada JR. Abnormal intestinal motility in diabetics with gastroparesis syndrome. Eur J Clin Investig. 1984;14:420–427.CrossRef Camilleri M, Malagelada JR. Abnormal intestinal motility in diabetics with gastroparesis syndrome. Eur J Clin Investig. 1984;14:420–427.CrossRef
Metadaten
Titel
Small Intestinal Bacterial Overgrowth in Gastroparesis
verfasst von
Nina S. George
Abhinav Sankineni
Henry P. Parkman
Publikationsdatum
01.03.2014
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 3/2014
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2426-7

Weitere Artikel der Ausgabe 3/2014

Digestive Diseases and Sciences 3/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.